ExploreWatchlistsPricing
  1. JP-listed companies
  2. KOBAYASHI PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Cost of revenue

KOBAYASHI PHARMACEUTICAL CO.,LTD. (4967)

Market cap
¥455.2B
P/E ratio
43.4x
Kobayashi Pharmaceutical makes healthcare products and consumer goods like deodorizers and oral care items, serving domestic and international markets through 40 subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCost of revenue (Million JPY)YoY (%)
Dec 31, 202581,030+3.89%
Dec 31, 202477,997+1.19%
Dec 31, 202377,079+4.26%
Dec 31, 202273,927+11.21%
Dec 31, 202166,478+1.89%
Dec 31, 202065,248+0.84%
Dec 31, 201964,705+0.54%
Dec 31, 201864,359+5.10%
Dec 31, 201761,238+25.91%
Dec 31, 201648,638-15.44%
Mar 31, 201657,518+5.12%
Mar 31, 201554,718

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat